Giovanni et al. showed that TM6SF2 rs58542926 can impact the nutrient oxidation, glucose homeostasis, and postprandial lipoprotein of adipokines in patients with NAFLD [43]. Here, TM6SF2 is linked to metabolic dysfunction-associated steatotic liver disease.